Patent · US Expired

4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors

US6821963B2 · kind B2 · utility

25Cited by
4References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2002
Grant dateNov 23, 2004
Priority date
Expiry dateJun 4, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/16
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Phenylamino benzhydroxamic acid derivatives of formula (I) where R1, R2, R3, R4, R5, and R6 are hydrogen or substituent groups such as alkyl, and where R7 is hydrogen or an organic radical, are potent inhibitors of MEK and, as such, are effective in treating cancer and other proliferative diseases such as psoriasis and restenosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.